|
1
|
Low daily dosage of interferon for 1 year after HCV-related end-therapy response. A randomized-controlled study.
|
Liver Int
|
2003
|
1.39
|
|
2
|
Non-alcoholic fatty liver disease in young adult severely obese non-diabetic patients in South Italy.
|
Ann Nutr Metab
|
2005
|
0.97
|
|
3
|
Circulating levels of cytochrome C, gamma-glutamyl transferase, triglycerides and unconjugated bilirubin in overweight/obese patients with non-alcoholic fatty liver disease.
|
J Biol Regul Homeost Agents
|
2011
|
0.91
|
|
4
|
A clinical-morphological study on cholestatic presentation of nonalcoholic fatty liver disease.
|
Dig Dis Sci
|
2005
|
0.88
|
|
5
|
Serum concentrations of the tissue polypeptide specific antigen in patients suffering from non-alcoholic steatohepatitis.
|
Eur J Clin Invest
|
2007
|
0.82
|
|
6
|
Does a lower insulin resistance affect antiviral therapy response in patients suffering from HCV related chronic hepatitis?
|
Gut
|
2006
|
0.81
|
|
7
|
Can serum TGF-beta 1 be used to evaluate the response to antiviral therapy of haemophilic patients with HCV-related chronic hepatitis?
|
Int J Immunopathol Pharmacol
|
2009
|
0.81
|
|
8
|
Acquired lecithin:cholesterol acyltransferase deficiency as a major factor in lowering plasma HDL levels in chronic kidney disease.
|
J Intern Med
|
2014
|
0.81
|
|
9
|
Does spleen volume play a role in patients with HCV-related chronic hepatitis?
|
Int J Immunopathol Pharmacol
|
2010
|
0.81
|
|
10
|
Long-term prophylaxis with intermediate-purity factor VIII concentrate (Haemate P) in a patient with type 3 von Willebrand disease and recurrent gastrointestinal bleeding.
|
Haemophilia
|
2006
|
0.78
|
|
11
|
Do thyroid abnormalities detected in patients treated for HCV-related chronic hepatitis persist?
|
Int J Immunopathol Pharmacol
|
2008
|
0.78
|
|
12
|
Rheumatoid factor after antiviral therapy in patients with HCV chronic hepatitis.
|
Clin Exp Rheumatol
|
2008
|
0.78
|
|
13
|
Should octreotide be used cautiously in liver cirrhosis with concomitant congestive heart failure correlated to coronary artery disease?
|
Dig Dis Sci
|
2003
|
0.77
|
|
14
|
Exaggerated immune reactions predict the outcome of interferon therapy in patients with chronic hepatitis C.
|
Int J Immunopathol Pharmacol
|
2008
|
0.77
|
|
15
|
Clinical presentation and prevalence of spontaneous bacterial peritonitis in patients with cryptogenic cirrhosis and features of metabolic syndrome.
|
Can J Gastroenterol
|
2004
|
0.77
|
|
16
|
Successful lamivudine monotherapy in an elderly patient suffering from HBV-related decompensated cirrhosis associated with widespread leukocytoclastic vasculitis.
|
Int J Immunopathol Pharmacol
|
2009
|
0.75
|
|
17
|
CD8+/CD38+: immune activity and clinical significance in HCV patients with and without interferon therapy.
|
Eur Rev Med Pharmacol Sci
|
2001
|
0.75
|
|
18
|
Could the depression of obese patients suffering from chronic hepatitis C be temporarily improved?
|
J Viral Hepat
|
2008
|
0.75
|